|
|
||||||||||||||
|
|
|||||||||||||||
CASE REPORT |
1 Department of Nephrology, Long Island Jewish Medical Center, New Hyde Park, New York, USA
2 Resident, Internal Medicine, Currently, Fellow in Nephrology, Metropolitan Hospital Center, New York, New York, USA
3 Department of Pathology, Bellevue Hospital, New York, New York, USA
4 Division of Endocrinology, Department of Internal Medicine, Metropolitan Hospital Center, New York, New York, USA
Correspondence to:
Correspondence to:
S G S Krishnan
Division of Kidney Diseases and Hypertension, Long Island Jewish Medical Center, 410 Lakeville Road, Suite 105, New Hyde Park, NY 11042, USA; sgskrishnan{at}hotmail.com
The case of a 39-year-old woman who was referred for weight gain and amenorrhoea is reported. Laboratory evaluation showed high levels of thyroid-stimulating hormone (TSH). The patient was started on increasing doses of levothyroxine for subclinical hypothyroidism. TSH remained persistently raised and the patient became thyrotoxic. Evaluation at another laboratory showed normal levels of TSH, raising the possibility of interfering substances. TSH levels were normalised with the addition of mouse serum to the patients sample, confirming the presence of human anti-mouse antibodies as the interfering substance in the TSH assay.
Abbreviations: TSH, thyroid-stimulating hormone; IgG, immuno-globulin G; HAMA, human anti-mouse antibody
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |